Concanavalin A-induced suppressor cell activity in untreated cancer cervix patients.
Satam, M N; Rajpal, R M; Nadkarni, J J.
Artículo en Inglés | IMSEAR | ID: sea-25999
Documentos relacionados
Metabolic modeling of single Th17 cells reveals regulators of autoimmunity.
Oral Treatment with BT-11 Ameliorates Inflammatory Bowel Disease by Enhancing Regulatory T Cell Responses in the Gut.
Anti-PD-1 Checkpoint Therapy Can Promote the Function and Survival of Regulatory T Cells.
Pembrolizumab Interferes with the Differentiation of Human FOXP3<sup>+</sup>-Induced T Regulatory Cells, but Not with FOXP3 Stability, through Activation of mTOR.
CTLA-4<sup>+</sup>PD-1<sup>-</sup> Memory CD4<sup>+</sup> T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy-Suppressed, SIV-Infected Rhesus Macaques.
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer.
Complanatuside A ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice by regulating the Th17/Treg balance via the JAK2/STAT3 signaling pathway.
Pharmacological inhibition of RORC2 enhances human Th17-Treg stability and function.
The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27.
The effect of Toll-like receptor stimulation on the motility of regulatory T cells.